Purple Biotech Ltd

TASE:PPBT Stock Report

Market Cap: ₪32.5m

Purple Biotech Dividends and Buybacks

Dividend criteria checks 0/6

Purple Biotech does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-94.8%

Buyback Yield

Total Shareholder Yield-94.8%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

We're A Little Worried About Purple Biotech's (TLV:PPBT) Cash Burn Rate

Mar 07
We're A Little Worried About Purple Biotech's (TLV:PPBT) Cash Burn Rate

Can Purple Biotech (TLV:PPBT) Afford To Invest In Growth?

Oct 30
Can Purple Biotech (TLV:PPBT) Afford To Invest In Growth?

Will Purple Biotech (TLV:PPBT) Spend Its Cash Wisely?

Jul 17
Will Purple Biotech (TLV:PPBT) Spend Its Cash Wisely?

Here's Why We're Watching Purple Biotech's (TLV:PPBT) Cash Burn Situation

Mar 13
Here's Why We're Watching Purple Biotech's (TLV:PPBT) Cash Burn Situation

Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Nov 27
Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Jul 21
Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

Mar 25
Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

Companies Like Purple Biotech (TLV:PPBT) Are In A Position To Invest In Growth

Dec 09
Companies Like Purple Biotech (TLV:PPBT) Are In A Position To Invest In Growth

Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

May 28
Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

We Think Purple Biotech (TLV:PPBT) Can Afford To Drive Business Growth

Feb 11
We Think Purple Biotech (TLV:PPBT) Can Afford To Drive Business Growth

If You Had Bought Purple Biotech's (TLV:KTOV) Shares Five Years Ago You Would Be Down 90%

Dec 21
If You Had Bought Purple Biotech's (TLV:KTOV) Shares Five Years Ago You Would Be Down 90%

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if PPBT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PPBT's dividend payments have been increasing.

Dividend Yield vs Market

Purple Biotech Dividend Yield vs Market
How does PPBT dividend yield compare to the market?
SegmentDividend Yield
Company (PPBT)n/a
Market Bottom 25% (IL)2.2%
Market Top 25% (IL)5.9%
Industry Average (Pharmaceuticals)1.8%
Analyst forecast (PPBT) (up to 3 years)n/a

Notable Dividend: Unable to evaluate PPBT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PPBT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate PPBT's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PPBT has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 00:58
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Purple Biotech Ltd is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emily BodnarH.C. Wainwright & Co.
Raghuram SelvarajuRodman & Renshaw, LLC